Cost of illness due to typhoid fever in five Asian countries

Tropical Medicine and International Health

Volumn 16, Issue 3, 2011, Pages 314-323

  Poulos, Christine ^a   Riewpaiboon, Arthorn ^b   Stewart, John F ^c   Clemens, John ^d   Guh, Soyeon ^c   Agtini, Magdarina ^e   Anh, Dang Duc ^f   Baiqing, Dong ^g   Bhutta, Zulfiqar ^h   Sur, Dipika ⁱ   Whittington, Dale ^c  

^a RTI INTERNATIONAL   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d International Vaccine Institute   (South Korea)

^e NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^f NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^g Guangxi Centers for Disease Prevention and Control   (China)

^h AGA KHAN UNIVERSITY   (Pakistan)

ⁱ NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

China; Cost of illness; India; Indonesia; Pakistan; Survey; Typhoid fever; Vietnam

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; TYPHOID VACCINE;

BLOOD; DEVELOPING WORLD; DISEASE TREATMENT; HEALTH SURVEY; HOSPITAL SECTOR; HOUSEHOLD INCOME; IMMUNIZATION; POLICY MAKING; PUBLIC HEALTH; VACCINE; WORLD HEALTH ORGANIZATION;

ADULT; ARTICLE; BLOOD CULTURE; CHILD; CHINA; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DEVELOPING COUNTRY; DISEASE DURATION; DRUG COST; DRUG TREATMENT FAILURE; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HOSPITALIZATION; HOUSEHOLD; HUMAN; INCOME; INDIA; INDONESIA; MAJOR CLINICAL STUDY; OUTPATIENT; PAKISTAN; TYPHOID FEVER; VIET NAM;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ASIA; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DEVELOPING COUNTRIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; TYPHOID FEVER; YOUNG ADULT;

CALCUTTA; CHINA; HUE; INDIA; INDONESIA; JAKARTA; KARACHI; PAKISTAN; SIND; VIET NAM; WEST BENGAL;

EID: 79951730629     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02711.x     Document Type: Article

References (23)

1. Asenso-Okyere WK & Dzator J (1997) Household cost of seeking malaria care. A retrospective study of two districts in Ghana. Social Science and Medicine 45(5), 659-667.
2. Bahl R, Sinha A, Poulos C et al. (2004) Costs-of-illness of typhoid fever in Indian urban slum community: implications for vaccination policy. Journal of Health, Population, and Nutrition 22(3), 304-310.
3. Cahn D, Whittington D, Thoa L et al. (2006) Household demand for typhoid fever vaccines in Hue, Vietnam: implications for immunization programs. Health Policy and Planning 21(3), 241-255.
4. Chima R, Goodman C & Mills A (2003) The economic impact of malaria in Africa: a critical review of the evidence. Health Policy 63, 17-36.
5. Cook J, Whittington D, Canh DG et al. (2007) The reliability of stated preferences for cholera and typhoid vaccines with time to think in Hue, Vietnam. Economic Inquiry 45(1), 100-114.
6. Cook J, Jeuland M, Poulos C et al. (2008) The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries. Vaccine 26(50), 6305-6316.
7. Cropper M, Lampietti J, Mitiku H, Poulos C & Whittington D (1999) The value of preventing malaria in Tigray, Ethiopia. Report to the World Health Organization.
8. Crump JA, Luby SP & Mintz ED (2004) The global burden of typhoid fever. Bulletin of WHO 82(5), 346-353.
9. DeRoeck D, Clemens J, Nyamete A & Mahoney R (2005) Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia. Vaccine 23, 2762-2774.
10. Forsberg BC, Sullesta E, Pieche S & Lambo N (1993) Cost of diarrhoeal diseases and the savings from a control programme in Cebu, Philippines. Bull WHO 171(5), 579-586.
11. Kaljee L, Thiem V, Seidlein L et al. (2004) Health care utilization for diarrhoea and dysentery in actual and hypothetical cases, Nha Trang, Viet Nam: options and choices. Journal of Health, Population, and Nutrition 22, 139-149.
12. Kim D, Cahn D, Poulos C et al. (2008) Private demand for cholera vaccines in Hue, Vietnam. Value in Health 11(1), 119-128.
13. Lerman SJ, Shepard DS & Cash RA (1985) Treatment for diarrhoea in Indonesian children: what it costs and who pays for it. The Lancet 326(8456), 651-654.
14. Lucas M, Jeuland M, Deen J et al. (2007) Private demand for cholera vaccines in Beira, Mozambique. Vaccine 25(14), 2599-2609.
15. Ochiai RL, Acosta CA, Danovaro-Holliday MC et al. (2007) A multicenter, population-based, prospective surveillance study of typhoid fever in 5 Asian countries: disease burden and implications for control. Bull WHO 86(4), 260-268.
16. Poulos C, Bahl R, Whittington D, Bahn MK, Clemens J & Acosta C (2004) A Cost-Benefit Analysis of Typhoid Fever Immunization Programs in an Indian Urban Slum Community. Journal of Health, Population, and Nutrition 22(3), 311-321.
17. Punjabi NH (1998) Cost evaluation of Typhoid Fever in Indonesia. Medical Journal of Indonesia 7 (Supplement 5-6), 90-93.
18. Riewpaiboon A (2007) Typhoid treatment cost at two hospitals in Kolkata, India. Draft Report to IVI.
19. Stewart JF (2005) Interim report on treatment costs. IVI Report.
20. Su TT, Kouyaté B & Fless S (2006) Catastrophic household expenditure for health care in a low-income society: a study from Nouna District, Burkina Faso. Bulletin of WHO 84, 21-27.
21. World Health Organization (WHO) (2008) Typhoid vaccines: WHO position paper. Weekly Epidemiological Record 83, 49-60.
22. World Health Organization (WHO) (1998) Report of the Scientific Group of Experts (SAGE), 9-11 June, 1998, Children's Vaccine Initiative and Global Programme on Vaccines. (WHO/GPV/98.06) WHO, Geneva.
23. Xu K, Evans D, Kawabata K, Zeramdini R, Klavus J & Murray C (2003) Household Catastrophic health expenditure: a multicountry analysis. Lancet 362, 111-117.